首页 | 本学科首页   官方微博 | 高级检索  
     

腰椎穿刺移植自体骨髓间充质干细胞治疗脑梗死后遗症6例
引用本文:焦红亮,关方霞,杨波,李建斌,詹三华,杜英,胡祥,赵琳娜,韩小改. 腰椎穿刺移植自体骨髓间充质干细胞治疗脑梗死后遗症6例[J]. 中国神经再生研究, 2010, 14(49): 9172-9175
作者姓名:焦红亮  关方霞  杨波  李建斌  詹三华  杜英  胡祥  赵琳娜  韩小改
作者单位:郑州大学第一附属医院神经外科,河南省郑州市 450052;河南省红十字血液中心,河南省郑州市 450014,郑州大学生物医学工程学系,河南省郑州市450052,郑州大学第一附属医院神经外科,河南省郑州市 450052,河南省红十字血液中心,河南省郑州市 450014,河南省武警总队医院普内科,河南省郑州市 450052,郑州大学基础医学院微生物与免疫学教研室,河南省郑州市450052,深圳市北科生物科技有限公司,广东省深圳市 518000,河南省红十字血液中心,河南省郑州市 450014,河南省红十字血液中心,河南省郑州市 450014
基金项目:郑州大学211工程三期重点学科建设项目;河南省医学科技创新人才工程项目(2005018)
摘    要:背景:骨髓间充质干细胞具有多向分化潜能,而且取材方便,扩增迅速,免疫原性低,在移植过程避免了免疫排斥等反应,是治疗脑梗死等神经系统疾病的理想种子细胞。目的:探讨自体骨髓间充质干细胞培养后经腰穿治疗脑梗死后遗症的安全性、可行性及疗效。方法:6例脑梗死后遗症患者进行自体骨髓间充质干细胞移植,骨穿采集自体骨髓单个核细胞,体外分离培养骨髓间充质干细胞4 d后经腰椎穿刺移植蛛网膜下腔,移植后观察疗效及并发症。结果与结论:培养后骨髓间充质干细胞数量明显增多,患者手术前后肌力和NIHSS评分通过统计分析有显著性差异(P < 0.05),总体症状改善较术前有明显改善;移植后无严重不良事件发生。结果提示,自体骨髓间充质干细胞培养后移植治疗可使脑梗死后遗症患者症状明显改善,治疗安全有效且不良反应小。

关 键 词:脑梗死后遗症;骨髓间充质干细胞;培养;移植;腰椎穿刺
收稿时间:2010-08-09
修稿时间:2010-08-09

Autologous bone marrow mesenchymal stem cell transplantation via lumbar puncture in the treatment of cerebral infarction sequelae in 6 cases
Jiao Hong-liang,Guan Fang-xi,Yang Bo,Li Jian-bin,Zhan San-hu,Du Ying,Hu Xiang,Zhao Lin-na and Han Xiao-gai. Autologous bone marrow mesenchymal stem cell transplantation via lumbar puncture in the treatment of cerebral infarction sequelae in 6 cases[J]. Neural Regeneration Research, 2010, 14(49): 9172-9175
Authors:Jiao Hong-liang  Guan Fang-xi  Yang Bo  Li Jian-bin  Zhan San-hu  Du Ying  Hu Xiang  Zhao Lin-na  Han Xiao-gai
Affiliation:Department of Neurosurgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China;Henan Province Red Cross Blood Center, Zhengzhou 450014, Henan Province, China,Department of Biomedical Engineering, Zhengzhou University, Zhengzhou 450052, Henan Province, China,Department of Neurosurgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China,Henan Province Red Cross Blood Center, Zhengzhou 450014, Henan Province, China,Department of General Internal Medicine, Henan Province Armed Police Forces Hospital, Zhengzhou 450052, Henan Province, China,Department of Microorganism and Immunology, Basic Medical College, Zhengzhou University, Zhengzhou 450052, Henan Province, China,Beike Bio-Technology Co., Ltd., Shenzhen 518000, Guangdong Province, China,Henan Province Red Cross Blood Center, Zhengzhou 450014, Henan Province, China,Henan Province Red Cross Blood Center, Zhengzhou 450014, Henan Province, China
Abstract:BACKGROUND: Bone marrow mesenchymal stem cells have multi-directional differentiation potential, and are easily, rapidly expanded, low immunogenicity, avoid immunological rejection in the transplant process, are ideal seed cells in the treatment of neurological diseases such as cerebral infarction. OBJECTIVE: To explore the safety, feasibility and efficacy of autologous bone marrow mesenchymal stem cell after culture transplantation via lumbar puncture in treatment of cerebral infarction. METHODS: A total of 6 cases of sequelae of cerebral infarction received autologous bone marrow mesenchymal stem cell transplantation. Autologous bone marrow mononuclear cells were collected by bone puncture. Bone marrow mesenchymal stem cells in vitro cultured 4 days after transplantation by lumbar puncture in the subarachnoid space. The efficacy and complications were observed after transplantation.RESULTS AND CONCLUSION: Numbers of BMSCs were significantly increased after culture. There were significant differences in NIHSS scores and muscle strength of patients before and after operation (P < 0.05) and the overall improvement of symptoms were improved significantly. After transplantation, there were no serious adverse events. The results suggest that autologous bone marrow mesenchymal stem cell transplantation can significantly improve symptoms in patients with cerebral infarction sequelae; treatment is safe, effective and low side effects.
Keywords:bone marrow   mesenchymal stem cells   cerebral infarction   culture
点击此处可从《中国神经再生研究》浏览原始摘要信息
点击此处可从《中国神经再生研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号